Article metrics

Download PDFPDF

Original research
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers

 

Online download statistics by month:

Online download statistics by month: June 2020 to September 2020

AbstractFullPdf
Jun 2020208208105
Jul 202018018068
Aug 2020757330
Sep 2020969636
Total559557239